IAIM
LAB icon

International Assets Investment Management’s Standard BioTools LAB Stock Holding History

International Assets Investment Management’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,940
Closed -$42K – 1240
2021
Q1 		$42K Hold
6,940
– – ﹤0.01% 1021
2020
Q4 		$42K Buy
+6,940
New +$45.6K 0.01% 900
2020
Q3 		– Sell
-55,750
Closed -$224K – 419
2020
Q2 		$224K Buy
+55,750
New +$194K 0.05% 289

Other funds holding LAB

ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

International Assets Investment Management's LAB Position: Q2 2021 in Review

International Assets Investment Management sold out of Standard BioTools (LAB) in Q2 2021, closing a stake of 6,940 shares — an estimated $42K sold.

International Assets Investment Management first reported a position in LAB in Q2 2020 and held it in 3 quarters. The position peaked at $224K in Q2 2020. 113 funds tracked by Wall St. Rank hold LAB as of Q2 2021.

  • International Assets Investment Management reported no remaining Standard BioTools position as of Q2 2021 after selling out during the quarter.
  • International Assets Investment Management sold 6,940 Standard BioTools shares in Q2 2021, an estimated $42K.
  • International Assets Investment Management first reported a position in Standard BioTools in Q2 2020 and held it in 3 quarters.
  • International Assets Investment Management's Standard BioTools position peaked at $224K in Q2 2020.
  • 113 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2021.

Based on International Assets Investment Management's 13F filing for Q2 2021, filed 14 Jul 2021.